This invention provides antibodies that specifically bind to and neutralize botulinum neurotoxin type A (BoNT/A) and the epitopes bound by those antibodies. The antibodies and derivatives thereof and/or other antibodies that specifically bind to the neutralizing epitopes provided herein can be used to neutralize botulinum neurotoxin and are therefore also useful in the treatment of botulism.

 
Web www.patentalert.com

< Treatment of optic and otic inflammation

> Carbon monoxide as a biomarker and therapeutic agent

> Polyalkylene glycol acid additives

~ 00534